A normal range of KL-6/MUC1 independent of elevated SP-D indicates a better prognosis in the patients with honeycombing on high-resolution computed tomography

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Hisata, Shu ^a   Kimura, Yuichiro ^a   Shibata, Naoko ^a   Ono, Shuichi ^b   Kobayashi, Takao ^c   Chiba, Shigeki ^a   Ohta, Hiromitsu ^a   Nukiwa, Toshihiro ^a   Ebina, Masahito ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c Sendai Kosei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; KL 6 ANTIGEN; MUCIN 1; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HONEYCOMBING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG FUNCTION TEST; MALE; NORMAL VALUE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SYMPTOM;

EID: 84868306676     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/806014     Document Type: Article

References (24)

1. Kim D. S., Collard H. R., King T. E. Jr., Classification and natural history of the idiopathic interstitial pneumonias Proceedings of the American Thoracic Society 2006 3 4 285 292 (Pubitemid 43845404)
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 American Journal of Respiratory and Critical Care Medicine 2002 165 277 304
3. Arakawa H., Fujimoto K., Honma K., Suganuma N., Morikubo H., Saito Y., Shida H., Kaji Y., Progression from near-normal to end-stage lungs in chronic interstitial pneumonia related to silica exposure: long-term CT observations American Journal of Roentgenology 2008 191 4 1040 1045
4. Kashiwabara K., Characteristics and disease activity of early interstitial lung disease in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung Chest 2006 129 2 402 406 (Pubitemid 43289861)
5. Rosas I. O., Ren P., Avila N. A., Chow C. K., Franks T. J., Travis W. D., McCoy J. P., May R. M., Wu H. P., Nguyen D. M., Arcos-Burgos M., MacDonald S. D., Gochuico B. R., Early interstitial lung disease in familial pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2007 176 7 698 705 (Pubitemid 47503078)
6. Tsushima K., Sone S., Yoshikawa S., Yokoyama T., Suzuki T., Kubo K., The radiological patterns of interstitial change at an early phase: over a 4-year follow-up Respiratory Medicine 2010 104 11 1712 1721
7. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., Shiratori M., Kuroki Y., Abe S., Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent American Journal of Respiratory and Critical Care Medicine 2000 162 3 1109 1114
8. Honda Y., Kuroki Y., Matsuura E., Nagae H., Takahashi H., Akino T., Abe S., Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids American Journal of Respiratory and Critical Care Medicine 1995 152 6 1860 1866
9. Kishore U., Greenhough T. J., Waters P., Shrive A. K., Ghai R., Kamran M. F., Bernal A. L., Reid K. B. M., Madan T., Chakraborty T., Surfactant proteins SP-A and SP-D: structure, function and receptors Molecular Immunology 2006 43 9 1293 1315 (Pubitemid 43356370)
10. Yokoyama A., Kondo K., Nakajima M., Matsushima T., Takahashi T., Nishimura M., Bando M., Sugiyama Y., Totani Y., Ishizaki T., Ichiyasu H., Suga M., Hamada H., Kohno N., Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Respirology 2006 11 2 164 168 (Pubitemid 43356896)
11. Kohno N., Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis Journal of Medical Investigation 1999 46 3-4 151 158 (Pubitemid 129622186)
12. Kohno N., Awaya Y., Oyama T., Yamakido M., Akiyama M., Inoue Y., Yokoyama A., Hamada H., Fujioka S., Hiwada K., KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease American Review of Respiratory Disease 1993 148 3 637 642 (Pubitemid 23263772)
13. Yokoyama A., Kohno N., Hamada H., Sakatani M., Ueda E., Kondo K., Hirasawa Y., Hiwada K., Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 1998 158 5 1680 1684
14. ATS statementSnowbird workshop on standardization of spirometry American Review of Respiratory Disease 1979 119 831 838
15. Takahashi H., Shiratori M., Kanai A., Chiba H., Kuroki Y., Abe S., Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D Respirology 2006 11 supplement 1 S51 S54
16. Kazarooni E. A., Martinez F. J., Flint A., Jamadar D. A., Gross B. H., Spizarny D. L., Cascade P. N., Whyte R. I., Lynch J. P., Toews G., Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring American Journal of Roentgenology 1997 169 4 977 983 (Pubitemid 27406888)
17. Kohno N., Kyoizumi S., Awaya Y., Fukuhara H., Yamakido M., Akiyama M., New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 Chest 1989 96 1 68 73 (Pubitemid 19176416)
18. Flaherty K. R., Toews G. B., Travis W. D., Colby T. V., Kazerooni E. A., Gross B. H., Jain A., Strawderman I. L., Paine R., Flint A., Lynch I. P., Martinez F. J., Clinical significance of histological classification of idiopathic interstitial pneumonia European Respiratory Journal 2002 19 2 275 283 (Pubitemid 34162828)
19. Yanaba K., Hasegawa M., Takehara K., Sato S., Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis Journal of Rheumatology 2004 31 6 1112 1120 (Pubitemid 38715886)
20. Kinder B. W., Brown K. K., McCormack F. X., Ix J. H., Kervitsky A., Schwarz M. I., King T. E., Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis Chest 2009 135 6 1557 1563
21. Satoh H., Kurishima K., Ishikawa H., Ohtsuka M., Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases Journal of Internal Medicine 2006 260 5 429 434 (Pubitemid 44571130)
22. Ebina M., Shibata N., Ohta H., The disappearance of subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis. Lympatic Reseach and Biology. In press
23. Wright J. R., Immunoregulatory functions of surfactant proteins Nature Reviews Immunology 2005 5 1 58 68 (Pubitemid 40070331)
24. Ebina M., Shimizukawa M., Shibata N., Kimura Y., Suzuki T., Endo M., Sasano H., Kondo T., Nukiwa T., Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2004 169 11 1203 1208 (Pubitemid 38680397)